|
Volumn 26, Issue 3, 2001, Pages 195-202
|
Transgene delivery with a cationic lipid in the presence of amyloid β (βAP) peptide
a a a a a a |
Author keywords
Alzheimer; Amyloid peptide; Cationic lipid; Gene therapy; Non viral
|
Indexed keywords
AMYLOID BETA PROTEIN;
AMYLOID BETA PROTEIN [25-35];
AMYLOID BETA PROTEIN [35-25];
LIPID;
LIPOSOME;
PLASMID DNA;
UNCLASSIFIED DRUG;
ALZHEIMER DISEASE;
ANIMAL CELL;
ARTICLE;
ATOMIC FORCE MICROSCOPY;
CELL CULTURE;
CONTROLLED STUDY;
CULTURE MEDIUM;
ELECTRON MICROSCOPY;
ENDOCYTOSIS;
FLOW CYTOMETRY;
FLUORESCENCE;
GENE EXPRESSION;
GENE TARGETING;
GENE THERAPY;
GENETIC TRANSFECTION;
HUMAN;
HUMAN CELL;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN STRUCTURE;
RAT;
STRUCTURE ACTIVITY RELATION;
STRUCTURE ANALYSIS;
TRANSGENE;
AMYLOID BETA-PROTEIN;
ANIMALS;
CELLS, CULTURED;
DNA;
ENDOCYTOSIS;
FLOW CYTOMETRY;
GENE TRANSFER TECHNIQUES;
HUMANS;
LIPIDS;
MICROSCOPY, ELECTRON;
PEPTIDE FRAGMENTS;
PLASMIDS;
RATS;
TRANSGENES;
TUMOR CELLS, CULTURED;
|
EID: 0034928303
PISSN: 03643190
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1010956231321 Document Type: Article |
Times cited : (4)
|
References (24)
|